Similar to ETV1, treatment with a MAP kinase inhibitor (PD0325901) also decreased ETV4 expression (unpublished data), suggesting that MAPK/ERK may be one of the multiple players regulating ETV4 expression and its association with Wnt signaling in GIST. The gene discussed is ETV4; the disease is gastrointestinal stromal tumor.